Prof Stephen D. Wiviott discusses the DECLARE TIMI-58 trial - The Dapagliflozin Effect on Cardiovascular Events.
Filmed by Radcliffe Cardiology on site at AHA 2018.
Video Category:
- Prevention & Risk Modification
Prof Stephen D. Wiviott discusses the DECLARE TIMI-58 trial - The Dapagliflozin Effect on Cardiovascular Events.
Filmed by Radcliffe Cardiology on site at AHA 2018.
